Researchers conducted a systematic review to assess the risk of bias and applicability of prediction models for fear of recurrence in patients with cancer.

Daratumumab produced rapid and sustained platelet responses in adults with immune thrombocytopenia (ITP), according to a recent single-center, open-label, phase 2 clinical trial (NCT05562882). Despite ...

The benefits of leadership huddles for nursing teams and patients are explored in this installment from an NCI-designated ...

In this study, researchers examined the US federal cancer research funding landscape in relation to mortality across major cancer types.